This track will explore the latest advancements in cardiac imaging techniques and angiographic procedures. Emphasis will be placed on improving diagnostic accuracy and patient outcomes through innovative imaging technologies.

This session focuses on the application of cardiac progenitor cells and regenerative therapies in treating cardiovascular diseases. Discussions will include current research and clinical trials aimed at enhancing cardiac repair and regeneration.

This track will examine the integration of artificial intelligence and machine learning in cardiology practices. Topics will cover predictive analytics, diagnostic tools, and personalized treatment plans driven by AI.

This session will highlight the latest innovations in cardiac devices, including pacemakers, defibrillators, and implantable monitors. The focus will be on how these technologies improve patient management and outcomes.

This track will address the evolving role of cardiac nursing in patient care and management. It will explore innovative practices and challenges faced by cardiac nurses in various healthcare settings.

This session will delve into the latest developments in cardiac pharmacology and the impact of new medications on cardiovascular health. Discussions will include drug efficacy, safety, and emerging therapies.

This track will focus on the importance of cardiac rehabilitation in improving patient outcomes post-cardiac events. It will explore evidence-based practices and future directions in rehabilitation programs.

This session will highlight recent advancements in cardiac surgery techniques and technologies. Emphasis will be placed on minimally invasive procedures and their impact on patient recovery.

This track will explore the intersection of cardiology and oncology, focusing on the cardiovascular implications of cancer treatments. Discussions will include risk assessment and management strategies for cancer survivors.

This session will present case studies and reports that illustrate unique challenges and solutions in clinical cardiology. Participants will engage in discussions on best practices derived from real-world experiences.

This track will examine the relationship between metabolic disorders and cardiovascular diseases, particularly focusing on diabetes and obesity. The session will address prevention strategies and management of stroke risk in affected populations.